Latest stories on SGMT
Cantor starts Sagimet at Overweight on potential in acne
The Fly63 · neutralanalyst
Sagimet Biosciences initiated with an Overweight at Cantor Fitzgerald
The Fly61 · neutralanalyst
Sagimet Biosciences upgraded to Overweight from Equal Weight at Barclays
The Fly61 · neutralanalyst
Barclays upgrades Sagimet stock rating on acne drug potential
Investing.com Analyst Ratings63 · neutralanalyst
Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Sagimet Biosciences advances AURORA clinical trial
The Fly63 · neutralproduct/pr
Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026
StockTitan63 · neutralproduct/pr
Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Sagimet Biosciences price target raised to $29 from $12 at Citizens
The Fly61 · neutralanalyst
Citizens raises Sagimet stock price target to $29 on acne drug
Investing.com Analyst Ratings61 · neutralanalyst
Sagimet higher on FDA clearance of late-stage acne trial
Seeking Alpha67 · bullishproduct/pr
Sagimet Biosciences Inc. (SGMT) files 8-K
SEC 8-K50 · neutralgeneral
Why is Sagimet Biosciences stock climbing today?
Investing.com Markets50 · neutralgeneral
Sagimet Biosciences reports Q2 EPS (26c), consensus (27c)
The Fly48 · neutralearnings
Sagimet Biosciences Inc. (SGMT) files 8-K
SEC 8-K50 · neutralgeneral
Sagimet Biosciences GAAP EPS of -$0.26 in-line
Seeking Alpha56 · neutralearnings
Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Business Insider56 · neutralgeneral
Sagimet: A Look Ahead To Earnings And A Catalyst-Heavy H2 2026
Seeking Alpha58 · neutralearnings
Sagimet Biosciences climbs 8% amid choppy trading in recent weeks
Seeking Alpha58 · neutralgeneral
Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
Business Insider56 · neutralgeneral
Sagimet Biosciences Inc. (SGMT) files 8-K
SEC 8-K50 · neutralgeneral
Sagimet Biosciences (SGMT) Attracts Attention After Russel Indexes Inclusion
Yahoo Top67 · bullishgeneral